当前位置: X-MOL首页全球导师 国内导师 › 贾伟平

个人简介

社会任职 上海市医学会内科专科分会主任委员 The Lancet Diabetes Endocrinology编委 中华医学会糖尿病学分会前任主任委员 国际糖尿病联盟西太区执委 亚洲糖尿病协会理事 《中华内科杂志》总编辑

研究领域

糖尿病、肥胖病的发病机制、诊断及治疗

近期论文

查看导师最新文章 (温馨提示:请注意重名现象,建议点开原文通过作者单位确认)

Hu C, Jia W*. (通讯作者) Diabetes in China: Epidemiology and Genetic Risk Factors and Their Clinical Utility in Personalized Medication. Diabetes. 2018 67(1):3-11. Li H, Wu G, Fang Q, Zhang M, Hui X, Sheng B, Wu L, Bao Y, Li P, Xu A*, Jia W*. (通讯作者) Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat. Nat Commun. 2018 9(1):272 Lu J, Ma X, Zhou J*, Zhang L, Mo Y, Ying L, Lu W, Zhu W, Bao Y, Vigersky RA, Jia W*. (通讯作者) Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes. Diabetes Care. 2018 41(11):2370-2376. Hu C, Jia W (通讯作者) Linking MTNR1B Variants to Diabetes: The Role of Circadian Rhythms. Diabetes 2016 65:1490- 1492 Zhang L, Guo KF, Lu JX, Zhao FY, Yu HY, Han JF, Bao YQ, Chen HB, Jia WP (通讯作者) Nonalcoholic Fatty Liver Disease is Associated with Increased Carotid Intima-Media Thickness in Type 1 Diabetic Patients Sci Rep 2016 6:26805 Yan J, Peng DF, Jiang F, Zhang R, Chen M, Wang T, Yan DD, Wang SY, Hou XH, Bao YQ, Hu C, Jia W (通讯作者) Impaired pancreatic beta cell compensatory function is the main cause of type 2 diabetes in individuals with high genetic risk: a 9 year prospective cohort study in the Chinese population Diabetologia 2016 59( 7): 1458- 1462 Wang T, Ma XJ, Peng DF, Zhang R, Sun X, Chen M, Yan J, Wang SY, Yan DD, He Z, Jiang F, Bao YQ, Hu C, Jia W (通讯作者) Effects of Obesity Related Genetic Variations on Visceral and Subcutaneous Fat Distribution in a Chinese Population. Sci Rep 2016 6:20691 Chen M, Zhang R, Jiang F, Wang J, Peng DF, Yan J, Wang SY, Wang T, Bao YQ, Hu C *, Jia WP (通讯作者) Joint effects of diabetic-related genomic loci on the therapeutic efficacy of oral anti-diabetic drugs in Chinese type 2 diabetes patients Sci Rep 2016 6:23266. Miao Chen, Cheng Hu*, Rong Zhang, Feng Jiang, Jie Wang, Danfeng Peng, Shanshan Tang, Xue Sun, Jing Yan, Shiyun Wang, Tao Wang, Yuqian Bao, Weiping Jia* (通讯作者) A variant of the PSMD6 gene is associated with the therapeutic efficacy of oral antidiabetic drugs in Chinese patients with type 2 diabetes Sci Rep 2015 5:10701 Haoyong Yu, Yan Ni, Yuqian Bao, Pin Zhang, Aihua Zhao, Tianlu Chen, Guoxiang Xie, Yinfang Tu, Lei Zhang, Mingming Su, Li Wei, Wei Jia, Weiping Jia* (通讯作者) Chenodeoxycholic Acid as a Potential Prognostic Marker for Roux-en-Y Gastric Bypass in Chinese Obese Patients J Clin Endocrinol Metab 2015 100(11): 4222-4230 Danfeng Peng, Jie Wang, Rong Zhang, Feng Jiang, Shanshan Tang, Miao Chen, Jing Yan, Xue Sun, Shiyun Wang, Tao Wang , Dandan Yan, Yuqian Bao, Cheng Hu*, Weiping Jia* (通讯作者) Common variants in or near ZNRF1, COLEC12, SCYL1BP1 and API5 are associated with diabetic retinopathy in Chinese patients with type 2 diabetes. Diabetologia 2015 58(6): 1231-1238 Weiping Jia* (通讯作者), Xinhua Xiao, Qiuhe Ji, Kyu-Jeung Ahn, Lee-Ming Chuang, Yuqian Bao, Can Pang, Lei Chen, Fei Gao, Yinfang Tu, Pengfei Li, Jun Yang Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin:an open-label, randomised, controlled trial Lancet Diabetes & Endocrinology 2015 Apr;3(4):254-262 Fang Q, Yang W, Li H, Hu W, Chen L,Jiang S, Dong K, Song Q,Wang C, Chen S, Liu F, Jia W (通讯作者) Negative regulation of DsbA-L gene expression by the transcription factor Sp1 Diabetes 2014 63(12):4165-4171 ChenM, Hu C,ZhangR, Jiang F, WangJ,PengD,TangS,SunX, YanJ,LuoY, BaoY and JiaW (通讯作者) Association of PAX4 genetic variants with oral antidiabetic drugs efficacy in Chinese type 2 diabetes patients Pharmacogenomics J 2014 14(5):488-92 Wu G, Li H, Fang Q, Jiang S, Zhang L, Zhang J, Hou X, Lu J, Bao Y, Xu A, Jia W (通讯作者) Elevated Circulating Lipocalin-2 Levels Independently Predict Incident Cardiovascular Events in Men in a Population-Based Cohort Arterioscler Thromb Vasc Biol 2014 34:2457-2464 Jiang S, Yan C, Fang Q, Shao M, Zhang Y, Liu Y, Deng Y, Shan B, Liu J,Li H, Yang L, Zhou J, Dai Z,Liu Y, Jia W (通讯作者) Fibroblast growth factor 21 is regulated by the IRE1α-XBP1 branch of the unfolded protein response and counteracts ER stress-induced hepatic steatosis J Biol Chem 2014 289(43): 29751-29765 Li H, Dong K, Fang Q, Hou X, Zhou M, Bao Y, Xiang K, Xu A, Jia W (通讯作者) High serum level of fibroblast growth factor 21 is an independent predictor of non-alcoholic fatty liver disease:A 3-year prospective study in China J of Hepatology 2013 58(3):557-63 Wang C, Li X, Mu K, Li L, Wang S, Zhu Y, Zhang M, Ryu J, Xie Z, Shi D, Zhang WJ, Dong LQ, Jia W. (通讯作者) Deficiency of APPL1 in mice impairs glucose-stimulated insulin secretion through inhibition of pancreatic beta cell mitochondrial function. Diabetologia 2013 56(9): 1999-2009 Li H, Gao Z, Zhang J, Ye X, Xu A, Ye J, Jia W (通讯作者) Sodium butyrate stimulates expression of fibroblast growth factor 21 in liver by inhibition of histone deacetylase 3 Diabetes 2012 61(4):797-806

推荐链接
down
wechat
bug